When cystic fibrosis hits your lungs hard, hit back. Everything you need to know about getting your lungs back into shape is ...

Some people with cystic fibrosis still do not have access to the life-changing modulator therapy drugs, despite wider EMA ...

A Wicklow mother is among a concerned group of parents who are calling for individual trials of the modulator therapies for ...

Adoption of Triple Combination Therapy Accelerates at Unprecedented Rates as Precision Medicine Revolution ContinuesRockville, MD, Jan. 29, 2025 (GLOBE NEWSWIRE) -- According to Fact.MR, a market ...

Discover the importance of vision, genetic eye disorders, and RNA-based therapies for precision treatment in India and ...

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), with its substantial $114.5 billion market capitalization, continues to dominate the cystic fibrosis (CF) treatment market while advancing a ...

Sophie would make a world record for being the first man or woman with cystic fibrosis to row across the Atlantic, while at ...

His rare gene means he is currently excluded from modulator therapy Kaftrio ... are being supported by Cystic Fibrosis Ireland, and believes the only solution for people with CF like Aaron ...

The bottom line is few companies can match its combination of established leadership in rare diseases and realistic pathways ...

Boehringer Ingelheim (BI) and the UK Cystic Fibrosis Gene Therapy Consortium announced a global collaboration to develop a first-in-class, long-term therapy for patients with cystic fibrosis (CF).

Vertex Pharmaceuticals Inc. (NASDAQ:VRTX), a leading biotechnology company specializing in cystic fibrosis (CF) treatments, has been making significant strides in expanding its therapeutic portfolio ...

FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.